SCHEMBL20847994

SCHEMBL20847994

Cc1cccc(NC(=O)c2cccc3ccccc23)c1

nearest known ligand 0.73

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.73
RAB9A P51151 3/20 0.73
KMT2A Q03164 8/20 0.68
MEN1 O00255 7/20 0.68
ALDH1A1 P00352 1/20 0.68
L3MBTL1 Q9Y468 1/20 0.63
POLB P06746 1/20 0.63
GAA P10253 2/20 0.62
DEGS1 O15121 1/20 0.61
TP53 P04637 1/20 0.61
MAPT P10636 1/20 0.61
MAOB P27338 2/20 0.60
ADORA3 P0DMS8 1/20 0.60
MAOA P21397 1/20 0.60
KCNK3 O14649 1/20 0.58
KCNK9 Q9NPC2 1/20 0.58
RXFP1 Q9HBX9 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27446979 0.89 NPC1 (0.75) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL5445792 0.86 ALDH1A1 (0.65) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL8133663 0.84 RAB9A (1.00) NPC1RAB9AKMT2AMEN1POLB
SCHEMBL31150345 0.84 DEGS1 (0.78) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL368228 0.84 DEGS1 (0.78) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL533767 0.83 KCNK3 (0.81) RAB9AKMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL14445599 0.82 MEN1 (0.58) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL19563743 0.82 MEN1 (0.58) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL15778699 0.82 FADS1 (0.68) NPC1RAB9AKMT2AMEN1DEGS1
SCHEMBL15778996 0.82 MEN1 (0.64) NPC1RAB9AKMT2AMEN1DEGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220017762-A1 INK JET INK FOR FORMING AN INFRARED ABSORBING IMAGE, INFRARED ABSORBING IMAGE FORMING METHOD, AND RECORDED MATERIAL FUJIFILM CORPORATION (JP) 2022-01-20 US disclosed
EP-3757179-A1 INK COMPOSITION FOR INKJET PRINTING, IMAGE FORMING METHOD, AND RECORDED MATERIAL Fujifilm Corporation (JP) 2020-12-30 EP disclosed
US-20200347252-A1 INK COMPOSITION FOR INK JET PRINTING, IMAGE FORMING METHOD, AND RECORDED MATERIAL FUJIFILM CORPORATION (JP) 2020-11-05 US disclosed
US-20190092720-A1 FUNCTIONALIZED BENZAMIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST HBV INFECTION BARUCH S BLUMBERG INST (US) 2019-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190092720-A1 FUNCTIONALIZED BENZAMIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST HBV INFECTION HAVCR2, PHB2, PHB1 NPC1 539/4885RAB9A 3534/4885KMT2A 2493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.